Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

Mar 4, 2026
Sale
Shares
15,084
Price
$187.90
Total Value
$2.83M
Shares Held After
123,772
% of Holdings
10.9%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
57
Price
$325.67
Total Value
$18.56K
Shares Held After
21,227
% of Holdings
0.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
75
Price
$324.88
Total Value
$24.37K
Shares Held After
21,284
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
210
Price
$323.84
Total Value
$68.01K
Shares Held After
21,359
% of Holdings
1.0%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
96
Price
$323.01
Total Value
$31.01K
Shares Held After
21,569
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
79
Price
$321.82
Total Value
$25.42K
Shares Held After
21,665
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
59
Price
$320.81
Total Value
$18.93K
Shares Held After
21,744
% of Holdings
0.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
28
Price
$320.01
Total Value
$8.96K
Shares Held After
21,803
% of Holdings
0.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
29
Price
$319.03
Total Value
$9.25K
Shares Held After
21,831
% of Holdings
0.1%

uniQure N.V. (QURE)

KLEMT CHRISTIAN — Chief Financial Officer
Mar 4, 2026
Sale
Shares
12,000
Price
$9.06
Total Value
$108.72K
Shares Held After
226,581
% of Holdings
5.0%

RHYTHM PHARMACEUTICALS, INC. (RYTM)

German Christopher Paul — Corporate Controller & CAO
Mar 4, 2026
Sale
Shares
5,614
Price
$89.56
Total Value
$502.79K
Shares Held After
160
% of Holdings
97.2%

DUCOMMUN INC /DE/ (DCO)

Mookerji Suman B. — Sr. V.P., C.F.O.
Mar 4, 2026
Sale
Shares
14,709
Price
$134.21
Total Value
$1.97M
Shares Held After
37,184
% of Holdings
28.3%
Mar 4, 2026
Sale
Shares
3,571
Price
$146.82
Total Value
$524.29K
Shares Held After
12,134
% of Holdings
22.7%

PepGen Inc. (PEPG)

McArthur James G — Director
Mar 4, 2026
Sale
Shares
131
Price
$6.33
Total Value
$828.58
Shares Held After
296,326
% of Holdings
0.0%

PepGen Inc. (PEPG)

McArthur James G — Director
Mar 4, 2026
Sale
Shares
5,144
Price
$6.23
Total Value
$32.05K
Shares Held After
296,457
% of Holdings
1.7%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

McKechnie Duncan — EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
2,437
Price
$475.30
Total Value
$1.16M
Shares Held After
15,122
% of Holdings
13.9%

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Daniell Richard — EVP, Europe Commercial
Mar 4, 2026
Sale
Shares
37,372
Price
$32.95
Total Value
$1.23M
Shares Held After
85,755
% of Holdings
30.4%

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Daniell Richard — EVP, Europe Commercial
Mar 4, 2026
Sale
Shares
20,461
Price
$32.46
Total Value
$664.26K
Shares Held After
123,127
% of Holdings
14.2%

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Daniell Richard — EVP, Europe Commercial
Mar 4, 2026
Sale
Shares
33,512
Price
$32.46
Total Value
$1.09M
Shares Held After
123,127
% of Holdings
21.4%

PepGen Inc. (PEPG)

Donnelly Noel — Chief Financial Officer
Mar 4, 2026
Sale
Shares
52
Price
$6.33
Total Value
$328.90
Shares Held After
111,603
% of Holdings
0.0%

PepGen Inc. (PEPG)

Donnelly Noel — Chief Financial Officer
Mar 4, 2026
Sale
Shares
2,032
Price
$6.23
Total Value
$12.66K
Shares Held After
111,655
% of Holdings
1.8%

Orthofix Medical Inc. (OFIX)

REINHARDT MAX — President, Global Spine
Mar 4, 2026
Sale
Shares
1,080
Price
$12.92
Total Value
$13.95K
Shares Held After
26,401
% of Holdings
3.9%
Mar 4, 2026
Sale
Shares
12,000
Price
$8.86
Total Value
$106.32K
Shares Held After
161,111
% of Holdings
6.9%

Global Business Travel Group, Inc. (GBTG)

Thompson John David — Chief Technology Officer
Mar 4, 2026
Sale
Shares
109,020
Price
$5.74
Total Value
$625.77K
Shares Held After
735,701
% of Holdings
12.9%
Mar 4, 2026
Sale
Shares
3,291
Price
$221.10
Total Value
$727.64K
Shares Held After
1,038
% of Holdings
76.0%
Mar 4, 2026
Sale
Shares
10,000
Price
$36.69
Total Value
$366.87K
Shares Held After
2,977,844
% of Holdings
0.3%

VERACYTE, INC. (VCYT)

Stapley Marc — Director
Mar 4, 2026
Sale
Shares
26,279
Price
$36.28
Total Value
$953.37K
Shares Held After
357,554
% of Holdings
6.8%

VERACYTE, INC. (VCYT)

Stapley Marc — Director
Mar 4, 2026
Sale
Shares
19,244
Price
$35.56
Total Value
$684.23K
Shares Held After
383,833
% of Holdings
4.8%

VERACYTE, INC. (VCYT)

Leite John — Chief Commercial Officer-CLIA
Mar 4, 2026
Sale
Shares
5,260
Price
$35.19
Total Value
$185.08K
Shares Held After
107,580
% of Holdings
4.7%

VERACYTE, INC. (VCYT)

McGuire Annie — SVP, General Counsel
Mar 4, 2026
Sale
Shares
1,664
Price
$36.34
Total Value
$60.47K
Shares Held After
94,706
% of Holdings
1.7%

VERACYTE, INC. (VCYT)

McGuire Annie — SVP, General Counsel
Mar 4, 2026
Sale
Shares
4,994
Price
$35.29
Total Value
$176.26K
Shares Held After
96,370
% of Holdings
4.9%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
223
Price
$325.67
Total Value
$72.62K
Shares Held After
61,805
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
291
Price
$324.88
Total Value
$94.54K
Shares Held After
62,028
% of Holdings
0.5%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
818
Price
$323.84
Total Value
$264.90K
Shares Held After
62,319
% of Holdings
1.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
374
Price
$323.01
Total Value
$120.81K
Shares Held After
63,137
% of Holdings
0.6%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
309
Price
$321.82
Total Value
$99.44K
Shares Held After
63,511
% of Holdings
0.5%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
230
Price
$320.81
Total Value
$73.79K
Shares Held After
63,820
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
109
Price
$320.01
Total Value
$34.88K
Shares Held After
64,050
% of Holdings
0.2%
Mar 4, 2026
Sale
Shares
2,425
Price
$12.92
Total Value
$31.32K
Shares Held After
91,109
% of Holdings
2.6%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
114
Price
$319.03
Total Value
$36.37K
Shares Held After
64,159
% of Holdings
0.2%

PepGen Inc. (PEPG)

STRECK PAUL — EVP, Head of R&D
Mar 4, 2026
Sale
Shares
47
Price
$6.29
Total Value
$295.54
Shares Held After
76,226
% of Holdings
0.1%

PepGen Inc. (PEPG)

STRECK PAUL — EVP, Head of R&D
Mar 4, 2026
Sale
Shares
1,832
Price
$6.23
Total Value
$11.41K
Shares Held After
76,273
% of Holdings
2.3%

Five9, Inc. (FIVN)

Meriweather Tiffany N. — Chief Admin. & Legal Officer
Mar 4, 2026
Sale
Shares
5,942
Price
$17.87
Total Value
$106.18K
Shares Held After
311,115
% of Holdings
1.9%
Mar 4, 2026
Sale
Shares
6,189
Price
$12.92
Total Value
$79.94K
Shares Held After
326,167
% of Holdings
1.9%

ADVANCED MICRO DEVICES INC (AMD)

Papermaster Mark D — Chief Technology Officer & EVP
Mar 4, 2026
Sale
Shares
3,034
Price
$200.00
Total Value
$606.80K
Shares Held After
1,297,759
% of Holdings
0.2%
Mar 4, 2026
Sale
Shares
15,793
Price
$27.53
Total Value
$434.78K
Shares Held After
16,026
% of Holdings
49.6%
Mar 4, 2026
Sale
Shares
1,171
Price
$12.92
Total Value
$15.12K
Shares Held After
165,859
% of Holdings
0.7%

Phillips 66 (PSX)

Mitchell Kevin J — Exec. VP and CFO
Mar 4, 2026
Sale
Shares
4,944
Price
$165.03
Total Value
$815.90K
Shares Held After
97,376
% of Holdings
4.8%

Orthofix Medical Inc. (OFIX)

Fisher Patrick — President, Global Limb Recon
Mar 4, 2026
Sale
Shares
778
Price
$12.92
Total Value
$10.05K
Shares Held After
51,391
% of Holdings
1.5%
Shares
163,100
Price
$44.86
Total Value
$7.32M
Shares Held After
26,469,098
% of Holdings
0.6%
Version: v26.3.33